Alirocumab Market

Alirocumab is a human monoclonal antibody. It works by helping the liver reduce levels of "bad" cholesterol (low-density lipoprotein, or LDL) circulating in your blood.Alirocumab is used in adults with heart disease to lower the risk of heart attack, stroke, and certain types of chest pain conditions (unstable angina) requiring hospitalization.
Alirocumab Market contains market size and forecasts of Alirocumab in global, including the following market information:
Global Alirocumab Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global Alirocumab Market Sales, 2017-2022, 2023-2028, (Kg)
Global top five Alirocumab companies in 2021 (%)
The global Alirocumab market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period 2022-2028.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
Patent Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Alirocumab include AK Scientific, Carbosynth, TargetMol Chemicals, Beijing Aomi Jiade Pharmaceutical Technology, Hefei Hirisun Pharmatech, Hubei Widely Chemical Technology, Hubei Xingcheng Biotechnology, Hubei Zhongshan Medical Technology and Jiangxi Ruiweier Biotechnology, etc. In 2021, the global top five players have a share approximately % in terms of revenue.
We surveyed the Alirocumab manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Alirocumab Market, by Type, 2017-2022, 2023-2028 ($ Millions) & (Kg)
Global Alirocumab Market Segment Percentages, by Type, 2021 (%)
Patent
Generic
Global Alirocumab Market, by Application, 2017-2022, 2023-2028 ($ Millions) & (Kg)
Global Alirocumab Market Segment Percentages, by Application, 2021 (%)
Biochemical Reagents
Pharmaceutical Intermediates
Global Alirocumab Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions) & (Kg)
Global Alirocumab Market Segment Percentages, By Region and Country, 2021 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Alirocumab revenues in global market, 2017-2022 (Estimated), ($ millions)
Key companies Alirocumab revenues share in global market, 2021 (%)
Key companies Alirocumab sales in global market, 2017-2022 (Estimated), (Kg)
Key companies Alirocumab sales share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
AK Scientific
Carbosynth
TargetMol Chemicals
Beijing Aomi Jiade Pharmaceutical Technology
Hefei Hirisun Pharmatech
Hubei Widely Chemical Technology
Hubei Xingcheng Biotechnology
Hubei Zhongshan Medical Technology
Jiangxi Ruiweier Biotechnology
Kailide Biomedical Technology
Nantong Feiyu Biological Technology
Nantong Hi-Future Biotechnology
Shanghai Baishikai Chemical Technology
Shanghai Biochempartner
Shanghai Loulan Biotechnology
Shanghai Macklin Biochemical
Shanghai Minkai Biotechnology
Shanghai Ruihui Chemical Technology
Shanghai Saimai Biotechnology
Shanghai Yifei Biotechnology
Sichuan Weiqi Biotechnology
Taizhou KEDE Chemical
Taizhou Kerui Bio-Technology
Tianmen Hengchang Chemical
WeiShi Reagent
Wuhan Dingxintong Pharmaceutical
Wuhan Fortuna Chemical
Wuhan Sunrise Technology Development
Wuhan Weisman Bioengineering